PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-12-03

Date Title Company
03-Dec-2025 Lantern Pharma Reports Additional Positive LP-184 Phase 1a Results Showing Durable Disease Control in Heavily Pre-Treated Advanced Cancer Patients as Company Advances Precision Oncology Program into Multiple Biomarker-Guided Phase 1b/2 Trials Businesswire
03-Dec-2025 EHC 2025: Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® for the Prevention of Chronic and Episodic Migraine Teva Pharmaceuticals
03-Dec-2025 Junevity Expands Seed Funding to $20 Million for Cell Reprogramming with siRNA Businesswire
03-Dec-2025 Excelsior Sciences Raises $95 Million to Transform Small Molecule Discovery and Manufacturing with Novel Chemistry that Machines Can Do Businesswire
03-Dec-2025 TRIANA Biomedicines Announces Oversubscribed $120M Series B Financing to Advance its Molecular Glue Degrader Pipeline Businesswire
03-Dec-2025 Meiji Seika Pharma Invests in Lyric Bio for Next-Generation Human Immunoglobulin Manufacturing Businesswire
03-Dec-2025 Avenacy to Attend 2025 ASHP Midyear Clinical Meeting and Exhibition Businesswire
03-Dec-2025 Alnylam Pharmaceuticals Announces Changes to Board of Directors Businesswire
03-Dec-2025 bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable Businesswire
03-Dec-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-Dec-2025 Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities Businesswire
03-Dec-2025 IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform IQVIA
03-Dec-2025 Brian Moran Cancer Institute to Open December 15, 2025 ACCESS Newswire
03-Dec-2025 2026 New Remote Patient Monitoring (RPM) CPT Codes ACCESS Newswire
03-Dec-2025 Bristol Myers Squibb Announces Continuation of ADEPT-2 Phase 3 Study in Psychosis Associated with Alzheimer's Disease Businesswire
03-Dec-2025 ELRIG Drug Discovery Survey Identifies Three High-Impact Areas for Life Science Exhibitor Success ELRIG Drug Discovery 2025
03-Dec-2025 Hospital Cybersecurity Leaders Identify Non-Negotiable Domains to Fund by 2028 ACCESS Newswire
03-Dec-2025 Taiho Oncology Europe announces the launch of Lytgobi®▼ (futibatinib) in the United Kingdom for eligible adult patients with a previously treated subtype of locally advanced or metastatic cholangiocarcinoma1 Businesswire
03-Dec-2025 Proscia Achieves SOC 2 Type II Certification, Strengthening Enterprise Trust Proscia
03-Dec-2025 NEW SPINOUT COGSTACK IS UNLOCKING THE POWER OF HEALTHCARE DATA THROUGH AI TO TRANSFORM CLINICAL CARE CogStack